We are live on ! Find out more
CMLTU

CM Life Sciences III Inc. Unit

Delisted

CMLTU was delisted on the 17th of December, 2021.

28 hedge funds and large institutions have $127M invested in CM Life Sciences III Inc. Unit in 2021 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 2 increasing their positions, 12 reducing their positions, and 33 closing their positions.

New
Increased
Maintained
Reduced
Closed

51% less funds holding

Funds holding: 5728 (-29)

56% less capital invested

Capital invested by funds: $291M → $127M (-$164M)

83% less repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 12

88% less first-time investments, than exits

New positions opened: 4 | Existing positions closed: 33

100% less funds holding in top 10

Funds holding in top 10: 10 (-1)

Holders
28
Holders Change
-29
Holders Change %
-50.88%
% of All Funds
0.49%
Holding in Top 10
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
New
4
Increased
2
Reduced
12
Closed
33
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
6CM
51
683 Capital Management
New York
-$1.09M -100,000 Closed
MS
52
Maven Securities
Jersey
-$1.09M -100,000 Closed
VF
53
Virtu Financial
New York
-$844K -77,032 Closed
ZDA
54
Zweig-DiMenna Associates
New York
-$820K -74,874 Closed
SC
55
Sculptor Capital
New York
-$735K -70,403 -100%
LCS
56
Levin Capital Strategies
New York
-$496K -45,318 Closed
RCM
57
Radcliffe Capital Management
Pennsylvania
-$274K -25,000 Closed
FTCM
58
First Trust Capital Management
Illinois
-$264K -24,114 Closed
Northern Trust
59
Northern Trust
Illinois
-$127K -11,618 Closed
SCC
60
Spring Creek Capital
Kansas
-$110K -10,000 Closed
First Manhattan
61
First Manhattan
New York
-$5K -500 Closed

CMLTU Hedge Fund Activity: Q3 2021 in Review

28 of the 5,713 institutional investors tracked by Wall St. Rank reported a position in CM Life Sciences III Inc. Unit (CMLTU) for Q3 2021, worth a combined $127M — down 56% from $291M a quarter earlier.

Sellers outnumbered buyers: 33 funds closed out of CMLTU and 4 opened new positions — a net loss of 29 holders — while 12 trimmed existing stakes and 2 added.

The largest buyer was Apollo Management Holdings, opening a new position worth an estimated $7.19M. The largest seller was TOMS Capital Investment Management, exiting entirely with an estimated $23.8M sold.

  • 28 institutional investors held CM Life Sciences III Inc. Unit (CMLTU) as of Q3 2021, down from 57 in Q2 2021.
  • Funds reported $127M of CM Life Sciences III Inc. Unit stock for Q3 2021, down 56% quarter-over-quarter.
  • 4 funds opened new CM Life Sciences III Inc. Unit positions in Q3 2021 and 33 closed out, a net change of -29 holders.
  • The largest CM Life Sciences III Inc. Unit buyer in Q3 2021 was Apollo Management Holdings, an estimated $7.19M added.
  • The largest CM Life Sciences III Inc. Unit seller in Q3 2021 was TOMS Capital Investment Management, an estimated $23.8M sold.

Based on aggregated 13F filings for Q3 2021.